跳至主要内容
临床试验/IRCT20220305054196N4
IRCT20220305054196N4招募中3 期

Investigating the effect of methylphenidate on the level of consciousness in loss of consciousness patients due to poisoning in Loghman Hakim Hospital in Tehran in 2023

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 64 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age 18 years and above
  • Informed consent of the legal guardian of the patient to participate in the study
  • Having decreased consciousness due to poisoning (GCS 13 and below)
  • Having the ability to move to measure the movement

排除标准

  • History of allergy to methylphenidate
  • Po intolerance
  • Unstable vital signs
  • Pregnancy and lactation in female patients
  • Receiving a specific antidote (example: Flumazenin, Naloxone, etc.)
  • Having mental retardation, blindness, deafness
  • Having a history of brain damage, high blood pressure, ischemic heart disease
  • Having epilepsy

研究者

相似试验

Investigating the effect of methylphenidate on the... | 临床试验